ALEXANDRIA, Va., June 12 -- United States Patent no. 12,298,305, issued on May 13, was assigned to UNM RAINFOREST INNOVATIONS (Albuquerque, N.M.).

"Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections" was invented by Tione Buranda (Albuquerque, N.M.), Jacob Ongudi Agola (Albuquerque, N.M.), Soumik BasuRay (Dallas), Scarlett Swanson (Albuquerque, N.M.), Angela Wandinger-Ness (Albuquerque, N.M.), Peter C. Simons (Albuquerque, N.M.) and Virginie Bondu (Albuquerque, N.M.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one embodiment, the invention provides a method of diagnosing sepsis or a virus-related infection (often a viral hemorrhagic fever infection) in a subject by d...